Director, Financial Planning & Analysis

Overview

Reporting to the Head of R&D Finance, the Director of R&D Financial Planning & Analysis is a key member of Alnylam's Finance team. This role will work closely with business leaders at all levels of the organization and will be focused on providing strategic financial support to the company's global development program teams.

This position ishybridand will be primarily located inCambridge, MA.

Key Responsibilities

• Serve as the financial representative on global development program teams working closely with Program Leaders, Program Managers and functional experts. Offer guidance and support from a financial perspective to program teams while proactively managing potential risks and opportunities in close alignment with Finance leadership.
• Provide strategic financial support (e.g. NPVs, IRR, etc.) for business case reviews to allow for thoughtful decision making by executive leadership. Present findings to program teams as well as senior leadership as appropriate.
• Develop new program financial dashboard in partnership with key stakeholders across Finance and the business. New dashboard will summarize program financial and operational status and other important data points.
• Support annual budgeting and long range planning processes by driving alignment on key assumptions between program teams and functional leadership and ensuring program team leadership is aligned on financial submissions.
• Collaborate with R&D Finance, CMC Finance and Alliance Finance teams to understand key drivers of variance between actual results and budgets/forecasts. Review variance analysis with program team leadership and recommend changes to plans as appropriate.
• Assist with the development of budgets for external partners in close collaboration with the Alliance Finance team.
• Develop strong relationships with members of the broader Finance organization and support special projects and ad hoc analyses as necessary.
• Support the growth and career development of more junior members of the R&D Finance team.

Qualifications

• Bachelor's Degree in Finance or other degrees with quantitative focus (e.g. Statistics, Econometrics, Mathematics) required. Relevant advanced degrees (e.g. MBA) preferred
• 10+ years work experience in a combination of FP&A, accounting, valuation and/or other strategic finance roles
• 6+ years of work experience in biotech / pharma industry, R&D experience required
• Must have strong working knowledge of financial valuation methodologies applied in a biotech / pharma setting
• Demonstrated ability to pivot between high-level strategic discussions and operationally executing on deliverables, ideally within a matrixed organization
• Excellent interpersonal skills and ability to work effectively with multiple functions and with stakeholders of various levels of seniority
• Proven ability to work with a high level of integrity, accuracy, and attention to detail
• Maintain a positive, flexible, client-service attitude with business teams

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.